Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

Patients with autoimmune multilineage cytopenias are often refractory to standard therapies requiring chronic immunosuppression with medications with limited efficacy and high toxicity. We present data on 30 patients treated on a multicenter prospective clinical trial using sirolimus as monotherapy....

Full description

Saved in:
Bibliographic Details
Published in:Blood
Main Authors: Bride, Karen L., Vincent, Tiffaney, Smith-Whitley, Kim, Lambert, Michele P., Bleesing, Jack J., Seif, Alix E., Manno, Catherine S., Casper, James, Grupp, Stephan A., Teachey, David T.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2016
Subjects:
Plenary Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4705607/
https://ncbi.nlm.nih.gov/pubmed/26504182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-07-657981
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items